• 1
    MURRAY CJ, LOPEZ AD. Global mortality, disability and the contribution of risk factors: global burden disease study. Lancet 1997;349:14361442.
  • 2
    ANGST J, SELLARO R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 2000;48:445457.
  • 3
    MACQUEEN GM, YOUNG LT, JOFFE RT. A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatr Scand 2001;103:163170.
  • 4
    MACQUEEN GM, YOUNG LT, ROBB JC, MARRIOTT M, COOKE RG, JOFFE RT. Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder. Acta Psychiatr Scand 2000;101:374381.
  • 5
    PEET M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994;164:549550.
  • 6
    JOFFE RT, MACQUEEN GM, MARRIOTT M, ROBB J, BEGIN H, YOUNG LT. Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant. Acta Psychiatr Scand 2002;105:427430.
  • 7
    MAJ M. The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence. Bipolar Disord 2000;2:93101.
  • 8
    TONDO L, HENNEN J, BALDESSSARINI RJ. Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 2001;104: 163172.
  • 9
    YOUNG LT, JOFFE RT, ROBB JC, MACQUEEN GM, MARRIOTT M, PATELIS-SIOTIS I. Double-blind comparison of addition of a second mood stabiliser versus an antidepressant to an initial mood stabiliser for treatment of patients with bipolar depression. Am J Psychiatry 2001; 157:124126.
  • 10
    NEMEROFF CB, EVANS DL, GYULAI L et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001;158:906912.
  • 11
    POST RM, FRYE MA, DENICOFF KD, SPARK AM, WEISS SRB, LEVERICH GS. Preliminary algorithms for treatment-resistant bipolar depression. 2001;Chapter 17.
  • 12
    CALABRASE JR, BOWDEN CL, SACHS GS, ASCHER JA, MONAGHAN E, RUDD GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar-I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999;60:7988.
  • 13
    FRYE MA, KETTER TA, KIMBRELL TA et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000;20:607614.
  • 14
    ANDERSON IM, NUTT DJ, DEAKIN JF. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology Guidelines. British Association for Psychopharmacology. J Psychopharmacol 2000;14: 320.
  • 15
    SACHS GS, PRINTZ DJ, KAHN DA, CARPENTER D, DOCHERTY JP. The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad Med Special Rep 2000(April):11, 2727.
  • 16
    FAEDDA GL, TONDO L, BALDESSARINI RJ, SUPPES T, TOHEN M. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiat 1993;50:448455.
  • 17
    RAMASUBBU R. Dose–response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders. Acta Psychiatr Scand 2001; 104:236238.DOI: 10.1034/j.1600-0447.2001.00383.x